GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (OTCPK:VYYRF) » Definitions » Net Issuance of Preferred Stock

VYYRF (Voyageur Pharmaceuticals) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Nov. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Voyageur Pharmaceuticals Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Voyageur Pharmaceuticals's net issuance of preferred for the three months ended in Nov. 2024 was $0.00 Mil. The number is 0, which means that Voyageur Pharmaceuticals has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Voyageur Pharmaceuticals's net issuance of preferred for the trailing twelve months (TTM) ended in Nov. 2024 was $0.00 Mil.

Voyageur Pharmaceuticals Net Issuance of Preferred Stock Historical Data

The historical data trend for Voyageur Pharmaceuticals's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Net Issuance of Preferred Stock Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voyageur Pharmaceuticals Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Voyageur Pharmaceuticals Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (OTCPK:VYYRF) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
XCNQ:GWAY XCNQ:AYR.A XCNQ:CXXI XCNQ:EPIC TSXV:ROMJ XCNQ:QNTM NEOE:CBST TSX:CWEB XCNQ:IAN XCNQ:LEEF ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
VM:Canada
Address
4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Website
https://www.voyageurpharmaceuticals.ca
Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring, and developing raw materials for pharmaceutical products. The company's products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD, and V-Gas.